The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Alveolar hemorrhage (AH), diffuse AH (DAH)
Publications
Warfarin-Induced Pulmonary Hemorrhage: A Rare and Life-Threatening Complication in the Resource-Limited Setting of Gaza.
Case reports in pulmonology 2025;2025 — 2025 — 8866411
Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation.
Case reports in medicine 2019;2019;4917856 — 2019 — 4917856
Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy.
Case reports in medicine 2015;2015;350532 — 2015 — 350532
A life-threatening complication of warfarin therapy in ED: diffuse alveolar hemorrhage.
The American journal of emergency medicine 2014 Jun;32;690.e3-4 — 2014 Jun — 690.e3-4
Successful management of warfarin-exacerbated diffuse alveolar hemorrhage using an extracorporeal membrane oxygenation.
Multidisciplinary respiratory medicine 2013 Feb 27;8;16 — 2013 Feb 27 — 16
Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status.
The New England journal of medicine 2007 Jan 11;356;174-82 — 2007 Jan 11 — 174-82
Diffuse alveolar hemorrhage secondary to superwarfarin ingestion.
Chest 1992 Oct;102;1301-2 — 1992 Oct — 1301-2